SMTL ID : 8d0e.1

Human SARM1 TIR domain bound to NB-7

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.88 Å

Oligo State

homo-dimer

Ligands

2 x Q0C: 3-(4-chlorophenyl)-N-[4-methyl-3-(pyridin-4-yl)-1H-pyrazol-5-yl]propanamide(Non-covalent)

Q0C.1: 11 residues within 4Å: Chain A: L.64, L.69, P.98, I.100, F.103, W.105, V.118, L.119, F.121, N.122, G.123 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:P.98, A:I.100, A:F.103, A:W.105, A:W.105, A:L.119 Hydrogen bonds: A:G.123 pi-Stacking: A:W.105, A:W.105 Q0C.2: 10 residues within 4Å: Chain B: L.64, L.69, P.98, F.103, W.105, V.118, L.119, F.121, N.122, G.123 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:P.98, B:F.103, B:W.105, B:W.105, B:L.119 Hydrogen bonds: B:G.123 Water bridges: B:N.122, B:N.122 pi-Stacking: B:W.105, B:W.105

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bratkowski, M. et al., Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease. Neuron (2022)

Release Date

2022-09-21

Peptides

NAD(+) hydrolase SARM1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

NAD(+) hydrolase SARM1

Related Entries With Identical Sequence